Big Movers: Ampio Pharmaceuticals (NYSEMKT:AMPE), Acceleron Pharma (NASDAQ:XLRN), Provectus Biopharmaceuticals (NYSEMKT:PVCT), Energy Recovery (NASDAQ:ERII), Nuveen California Dividend Advantage Municipal Fund 2 (NYSEMKT:NVX)

Ampio Pharmaceuticals, Inc. (NYSEMKT:AMPE) belongs to Healthcare sector. Its weekly performance is 9.58%. On last trading day company shares ended up $2.63. Ampio Pharmaceuticals, Inc. (NYSEMKT:AMPE) distance from 50-day simple moving average (SMA50) is 6.26%. Ampio Pharmaceuticals, Inc. (NYSEMKT:AMPE) announced dial-in details for a scheduled investor call to discuss updates on its two pipeline products, AmpionTM and OptinaTM on Thursday, July 16 at 4:30 p.m. EDT.

Acceleron Pharma, Inc. (NASDAQ:XLRN) shares increased 0.23% in last trading session and ended the day at $30.10. XLRN return on assets is -29.20%. Acceleron Pharma, Inc. (NASDAQ:XLRN) quarterly performance is -11.47%. On 6 July, Acceleron Pharma, Inc. (NASDAQ:XLRN) said that, it provides an overview of the Acceleron Pharma, Inc.’s pharmaceutical research and development focus.

On 13 July, Provectus Biopharmaceuticals, Inc. (NYSEMKT:PVCT) shares remains unchanged and was closed at $0.51. PVCT EPS growth in last 5 year was 22.20%. Provectus Biopharmaceuticals, Inc. (NYSEMKT:PVCT) year to date (YTD) performance is -36.25%. On 2 July, Provectus Biopharmaceuticals, Inc. (NYSEMKT:PVCT) announced that it has signed a Letter of Intent (the “LOI”) with Boehringer Ingelheim (China) Investment Co. Ltd. (“Boehringer”). The purpose of the LOI is to lay a foundation for the two parties to collaborate in bringing PV-10, Provectus’ novel investigational drug for cancer (“PV-10”), to market in mainland China, Hong Kong and Taiwan. Maxim Group LLC acted as strategic advisor to Provectus in structuring and negotiating the LOI.

Energy Recovery, Inc. (NASDAQ:ERII) ended the last trading day at $2.80. Company weekly volatility is calculated as 7.44% and price to cash ratio as 5.08. Energy Recovery, Inc. (NASDAQ:ERII) showed a weekly performance of 11.11%.Energy Recovery, Inc. (NASDAQ:ERII) announced it will release its financial results for the period ended June 30, 2015 on Thursday, August 6, 2015 after the market close.

Nuveen California Dividend Advantage Municipal Fund 2 (NYSEMKT:NVX) shares fell -0.94% in last trading session and ended the day at $13.64. Nuveen California Dividend Advantage Municipal Fund 2 (NYSEMKT:NVX) quarterly performance is -4.73%.Nuveen California Dividend Advantage Municipal Fund 2 (NYSEMKT:NVX) announced a cash dividend payment of $0.07 per share is scheduled to be paid on August 03, 2015. Shareholders who purchased NVX prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 14th quarter that NVX has paid the same dividend. At the current stock price of $13.65, the dividend yield is 6.15%.

Leave a Reply

Your email address will not be published. Required fields are marked *